/Companies

Complix

14 known investors

Find your way into Complix

Sign up to see every warm intro you have to Complix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Complix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions. The company focuses on cell-penetrating therapeutics designed to reach intracellular disease targets.

Investors · 14

Also in the syndicate · 9

Baekeland FundBiotech Fund FlandersleadCRP-SantéEdmond de Rothschild Investment PartnersleadGemma Frisius FundLRMTrustCapitalVesalius BiocapitalVinnof

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries BJun 2013

    Biotech Fund Flanders (lead), Edmond de Rothschild Investment Partners (lead), Gimv (lead), Baekeland Fund, CRP-Santé, Gemma Frisius Fund, LRM, OMNES Capital, TrustCapital, Vesalius Biocapital, Vinnof

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 1

Companies working in the same space as Complix.

In the news

Frequently asked questions

What does Complix do?
Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions. The company focuses on cell-penetrating therapeutics designed to reach intracellular disease targets.
Who are Complix's investors?
Complix's investors include PMV, Andera Partners, Vesalius Biocapital Partners, Gimv, Omnes Capital.